ArticleJournal of microbiology and biotechnology2026
Multi-Layered Antidepressant Mechanisms of Gami-Soyosan in a Corticosterone-Induced Mouse Model.
Article in Journal of microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the antidepressant-like effects of Gami-Soyosan (GSS) in a corticosterone-induced mouse model of depression. Behavioral assessments, including the forced swim test and tail suspension test, demonstrated that GSS significantly reduced immobility, indicating improved coping behaviors comparable to those of fluoxetine. Serum analysis revealed that GSS lowered pro-inflammatory cytokines such as IL-6, IL-1β, and TNF-α, indicating an attenuation of systemic inflammatory cytokine responses in this model. Metabolomic profiling further showed that GSS modulated amino acid and nitrogen-related pathways, including branched-chain amino acids, arginine, and histidine/β-alanine metabolism, supporting the restoration of metabolic homeostasis under stress. Distinct metabolic signatures were also observed when compared to fluoxetine, indicating that GSS may exert antidepressant-like effects through partially different mechanisms. In addition,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.